Related Experiment Video
Updated: May 16, 2026
06:46
Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
Published on: February 15, 2019
Chemokines in tissue fibrosis.
Hacer Sahin1, Hermann E Wasmuth
1Medical Department III, University Hospital Aachen, RWTH Aachen, Germany.
Biochimica Et Biophysica Acta
|November 20, 2012
Summary
Chemokines, or chemotactic cytokines, are key drivers of tissue fibrosis by mediating immune cell recruitment, fibroblast proliferation, and angiogenesis. Understanding their roles offers potential therapeutic targets for chronic organ damage.
Area of Science:
- Pathology
- Immunology
- Cell Biology
Background:
- Tissue fibrosis, characterized by scarring, arises from chronic wound healing, inflammation, and angiogenesis.
- Key hallmarks include immune cell recruitment, fibroblast proliferation, and extracellular matrix accumulation.
- Chemokines (chemotactic cytokines) are increasingly recognized as central mediators in these fibrotic processes.
Purpose of the Study:
- To explore the multifaceted roles of chemokines in the initiation and progression of tissue fibrosis.
- To highlight the involvement of chemokines beyond immune cell trafficking, including fibroblast activation and angiogenesis.
- To discuss the implications of chemokine actions in various organs and their translational relevance.
Main Methods:
- Review of existing literature on chemokine function in fibrotic diseases.
- Analysis of studies investigating chemokine involvement in liver, kidney, lung, and skin fibrosis.
- Comparison of common and tissue-specific chemokine effects across different organ systems.
Main Results:
- Chemokines orchestrate not only immune cell influx but also fibroblast activation and angiogenesis in fibrosis.
- Both common and organ-specific chemokine effects are observed in various fibrotic conditions.
- Animal model data provides insights but requires careful extrapolation to human trials.
Conclusions:
- Chemokines are critical regulators of tissue fibrosis through diverse mechanisms.
- Targeting chemokines presents a promising strategy for developing novel therapies for chronic organ damage.
- Further research into chemokine biology is essential for advancing fibrosis treatment.
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:28Phases of Wound Repair
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
01:09Introduction to Fibroblasts
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
01:26Extracellular Matrix
Unlike epithelial tissue, which is composed of cells closely packed with little or no extracellular space in between, connective tissue cells are dispersed in a matrix. This extracellular matrix (ECM) is composed of fibrous proteins like collagen, elastin, and fibronectin in a ground substance consisting of interstitial fluid, cell adhesion proteins, and proteoglycans. The proteoglycans form a gel-like material in the spaces between cells and provide hydration, buffering, binding, and force...
01:23Role of Matrix Metalloproteases in Degradation of ECM
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
A...